Description: ADB-5’Br-PINACA is a novel synthetic cannabinoid which is structurally related to ADB-5’Br-BINACA (or ADB-5’Br-BUTINACA), ADB-PINACA, and other similar indazole carboxamides. In May 2022, ADB-5’Br-BINACA was detected for the first time in the United States. Due to its novelty, little information is currently known about ADB-5’Br-PINACA.

Sample Source: Center of Forensic & Digital Science Abu Dhabi Judicial Department

Sample Appearance: The evidence appeared as a small square paper with letters printed on it. The sample was submitted to and first analyzed by the Center of Forensic & Digital Science in September 2022.

Pharmacology: The activity and potency of ADB-5’Br-PINACA are unknown. Based on structural similarity, ADB-5’Br-PINACA is expected to have similar effects to other synthetic cannabinoids.

Toxicology: ADB-5’Br-PINACA has not been detected in toxicology samples at the CFSRE.

Drug Materials: ADB-5’Br-PINACA has been identified in one drug material (Abu Dhabi) at the CFSRE.

Demographics / Geographics: No information is available at this time.

Legal Status: ADB-5’Br-PINACA is not explicitly scheduled in the United States. ADB-5’Br-PINACA appears to fall outside the scope of the national class-wide scheduling action imposed by China in July 2021.